$3.6M Hemispherx Securities Settlement Gets Final OK
A federal judge has given final approval to a $3.6 million settlement between Hemispherx Biopharma Inc. and a class of plaintiffs who alleged the company misled investors on the approval status...To view the full article, register now.
Already a subscriber? Click here to view full article